Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saif Zaman

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Drug Design, Development and Therapy|January 26, 2019
A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2<sup>+</sup> breast cancerRicardo Costa, Saif Zaman, Susan Sharpe, et al.
Breast Cancer Research and Treatment|September 20, 2018
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival ratesWei Lue Tong, Blake M Callahan, Yaping N Tu, et al.
Biochemical and Biophysical Research Communications|June 29, 2018
Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiformeSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 13, 2010
MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancerYi Chen, Mohd Saif Zaman, Guoren Deng, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 26, 2019
Potential MMP2-mediated availability of HLA binding, mutant ECM peptides reflects better melanoma survival rates and greater T-cell infiltratesSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.
Clinical Biochemistry|November 12, 2018
MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltrationSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.
Cancer Informatics|June 14, 2023
Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme ExpressionNagehan Pakasticali, Andrea Chobrutskiy, Dhruv N Patel, et al.
Viral Immunology|April 22, 2020
Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer AnalysisSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.
Microscopy Research and Technique|July 9, 2005
Imaging and analysis of Bacillus anthracis spore germinationMohd Saif Zaman, Anita Goyal, Gyanendra Prakash Dubey, et al.
Leukemia & Lymphoma|February 24, 2021
Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival ratesTaha I Huda, Moody Mihyu, Etienne C Gozlan, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Drug Design, Development and Therapy|January 26, 2019
A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2<sup>+</sup> breast cancerRicardo Costa, Saif Zaman, Susan Sharpe, et al.
Breast Cancer Research and Treatment|September 20, 2018
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival ratesWei Lue Tong, Blake M Callahan, Yaping N Tu, et al.
Biochemical and Biophysical Research Communications|June 29, 2018
Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiformeSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 13, 2010
MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancerYi Chen, Mohd Saif Zaman, Guoren Deng, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 26, 2019
Potential MMP2-mediated availability of HLA binding, mutant ECM peptides reflects better melanoma survival rates and greater T-cell infiltratesSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.
Clinical Biochemistry|November 12, 2018
MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltrationSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.
Cancer Informatics|June 14, 2023
Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme ExpressionNagehan Pakasticali, Andrea Chobrutskiy, Dhruv N Patel, et al.
Viral Immunology|April 22, 2020
Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer AnalysisSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.
Microscopy Research and Technique|July 9, 2005
Imaging and analysis of Bacillus anthracis spore germinationMohd Saif Zaman, Anita Goyal, Gyanendra Prakash Dubey, et al.
Leukemia & Lymphoma|February 24, 2021
Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival ratesTaha I Huda, Moody Mihyu, Etienne C Gozlan, et al.
Pageof 6